v3.25.2
Statements of Changes in Shareholders' Deficit - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Apr. 26, 2023
Balance, shares at Apr. 26, 2023      
Remeasurement of ordinary shares subject to possible redemption   (199,848) (199,848)
Net income 171,389 171,389
Balance – April 27, 2023 (inception)
Issuance of Founder Shares to Sponsor, shares      
Sale of public units through public offering $ 690 68,999,310 69,000,000
Sale of public units through public offering, shares 6,900,000      
Sale of Private Placement Units $ 33 3,319,967   3,320,000
Sale of Private Placement Units, shares 332,000      
Offering costs (2,070,665)   (2,070,665)
Deferred underwriting costs (690,000) (690,000)
Issuance of representative shares $ 7 (7)
Issuance of representative shares, shares 69,000      
Ordinary shares subject to redemption $ (690) (69,689,310) (69,690,000)
Ordinary shares subject to redemption, shares (6,900,000)      
Accretion of additional paid in capital to accumulated deficit (105,878) (105,878)
Balance at Dec. 31, 2023 $ 213 (134,337) (134,124)
Balance, shares at Dec. 31, 2023 2,126,000      
Extension funds attributable to common stock subject to redemption (277,700) (277,700)
Remeasurement of ordinary shares subject to possible redemption (3,617,001) (3,617,001)
Net income 2,552,215 2,552,215
Balance at Dec. 31, 2024 $ 213 $ (1,476,823) $ (1,476,610)
Balance, shares at Dec. 31, 2024 2,126,000